Traders cheer after the company reports upbeat fourth-quarter results and shares a bullish outlook.
Shares crater after the company provides investors with terrible clinical news.
A solid end to 2018 allows management to return even more capital to shareholders.
Surprise turnover in the corner office is spooking traders.
Lavish spending on additions to the company's growing software business took a toll on net income.
Risk-averse investors might be surprised how safe some of these companies are in one of the most volatile sectors on the market.
It's a battle between a healthcare conglomerate and the granddaddy of biotech. Which is the better choice for investors today?
Traders cheer a mixed earnings report. Here's what investors need to know.
These rock-solid growth stocks are great buys at today's prices.
Most charts are useless, but these five can make you a better stock picker.
Shares of the digital-printing company fall hard after the company provides investors with a sneak peek at its quarterly results.
Shares rose sharply after management released upbeat clinical data and scheduled a conference call.
The market is making some investors nervous, but you don’t have to give up tech altogether to make your portfolio safer.
These three dividend beasts stand apart from the crowd.
The Latin American e-commerce giant is going places.
Shares fall hard in response to an analyst downgrade. Here's what investors need to know.
Traders are feeling giddy after management shared the bull case for owning its stock at an important investor conference.
Declining revenue growth rates might not have pleased traders, but it wasn't a bad year for the business.
It was a banner year for the medical device maker.
Traders cheer after the company reports pleasing preliminary results for the fourth quarter and shares bullish guidance.